Arrowhead Research - 株価

ARWR

69.81

毎日の変更:

5.61%

毎年:

94.24%

価格 日 年
Agios Pharmaceuticals 56.18 0.43 0.77% 23.07%
Alnylam Pharmaceuticals 132.41 3.78 2.94% -8.17%
Anika Therapeutics 42.57 1.07 2.58% 43.00%
Arena Pharmaceuticals 62.68 -0.59 -0.93% 23.97%
Arrowhead Research 69.81 3.71 5.61% 94.24%
Bluebird Bio 29.50 1.10 3.87% -48.12%
Cerulean Pharma 1.31 0.02 1.55% 20.18%
Dicerna Pharmaceuticals 26.86 0.96 3.71% 13.48%
Heron Therapeutics 18.48 0.92 5.24% 25.97%
Intercept Pharmaceuticals 18.20 1.25 7.37% -79.56%
YTE 80.64 -0.75 -0.92% -16.64%
Ionis Pharmaceuticals 36.69 0.45 1.24% -34.59%
Ligand Pharmaceuticals 130.53 3.87 3.06% 27.02%
Merck & Co 77.46 -0.71 -0.91% 0.35%
Moderna Inc 158.89 0.34 0.21% 154.84%
Mirati Therapeutics 150.54 2.91 1.97% 38.82%
Nektar Therapeutics 19.29 -0.44 -2.23% -11.23%
Novartis 78.92 -0.52 -0.65% -5.85%
Opko Health 3.42 -0.12 -3.25% 40.74%
Ultragenyx Pharmaceutical 108.48 -0.77 -0.70% 63.64%
Spectrum Pharmaceuticals 3.12 0.05 1.63% -1.27%
Sarepta Therapeutics 71.02 0.99 1.41% -46.56%
TG Therapeutics 37.52 -0.38 -1.00% 88.21%
Vertex Pharmaceuticals 213.00 0.10 0.05% -22.96%
Xencor 38.62 0.48 1.26% 16.15%

価格 日 年
NASDAQ 13389 -12.43 -0.09% 48.73%
US2000 2206 -5.71 -0.26% 73.02%
US400 2712 -24.23 -0.89% 69.05%

ARWR:US
資産
現金と同等
流動資産
流動負債
負債
EBIT
EBITDA
株当たりのEPS利益
自己資本および準備金
借入資本
時価総額
当期純利益
営業経費
営業利益
普通株資本
収益へのPE価格
税引前利益
販売収入
販売および管理費
株式
貿易債権者
貿易債務者